CLINICAL STUDIES
Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices
P. Syamasundar Rao, MD, FACC*,
Felix Berger, MD ,
Christian Rey, MD ,
Jorge Haddad, MD||,
Bernhard Meier, MDFACC ,
Kevin P. Walsh, MDf,
Jay S. Chandar, MD, FACC#,
Thomas R. Lloyd, MD, FACC**,
Jose Suarez de Lezo, MD ,
Rolando Zamora, MD ,
Eleftherios B. Sideris, MD|| for the International Buttoned Device Trial Group
* Saint Louis University School of Medicine, St. Louis, Missouri, USA
German Heart Institute, Berlin, Germany
Université de Lille, Lille, France
|| Hospital do Coracão de Ribeirão, Ribeiräo Preto, Brazil
University Hospital, Bern, Switzerland
f Alder Hey Childrens Hospital, Liverpool, United Kingdom
# University of Miami/Jackson Memorial Hospital, Miami, Florida, USA
** University of Michigan/C.S. Mott Childrens Hospital, Ann Arbor, Michigan, USA
 Hospital Reina Sofia, Cordoba, Spain
 University of Arizona Health Sciences Center, Tucson, Arizona, USA
|| Athenian Institute of Pediatric Cardiology, Athens, Greece
Manuscript received July 30, 1999;
revised manuscript received February 16, 2000,
accepted March 28, 2000.
Reprint requests and correspondence: Dr. P. Syamasundar Rao, Professor of Pediatrics, Division of Pediatric Cardiology, Saint Louis University School of Medicine, 1465 South Grand Boulevard, Saint Louis, Missouri 63104-1095 raops{at}slu.edu
OBJECTIVES
The purpose of this study was to assess safety and effectiveness of the fourth generation buttoned device in closing atrial septal defects (ASDs) and to test the hypothesis that introduction of double button reduces unbuttoning rate without reducing effectiveness.
BACKGROUND
Because of the high unbuttoning rate (7.2%) with first, second and third generation buttoned devices, the device was modified (fourth generation) so that there were two radiopaque spring buttons 4 mm apart on the button loop attached to the occluder.
METHODS
During a four-year period ending in September 1997, 423 patients, ages 1.5 to 80 years (median 16 years), underwent closure of ASD at 40 medical centers around the world.
RESULTS
The ASD size varied between 5 and 30 mm (median 17 mm). The device size varied between 25 and 60 mm. Unbuttoning occurred in 4 (0.9%) of 423 patients. Effective occlusion, defined as no (n = 343) or trivial (n = 34) residual shunt on echo-Doppler studies performed within 24 h of the procedure, was demonstrated in 377 patients (90%). Thus, the unbuttoning rate (0.9 vs. 7.2%) decreased (p < 0.01) while effective occlusion rate (90 vs. 92%) remained unchanged (p > 0.1) with this device, compared with earlier generation devices. During follow-up from one month to five years (23 ± 15 months), 21 (5%) of 417 patients required surgical (n = 12) or transcatheter (n = 9) reintervention, mostly to treat significant residual shunt. In the remaining patients there was gradual reduction and disappearance of the residual shunt. No wire integrity problems were observed.
CONCLUSIONS
These data suggest that the fourth generation buttoned device is as effective as earlier generation devices, but without significant unbuttoning. Follow-up results remained good, with a reintervention-free rate of 89% at five years.
|
Abbreviations and Acronyms
| | ASD | = atrial septal defect | | ASDOS | = atrial septal defect occluding system | | BD | = buttoned device | | ECHO | = echocardiogram | | FDA | = Food and Drug Administration | | PFO | = patent foramen ovale | | Qp:Qs | = pulmonary to systemic flow ratio |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Ghosh, A. K. Ghosh, and S. K. Ghosh
Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke
Postgrad. Med. J.,
March 1, 2007;
83(977):
173 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Nugent, A. Britt, K. Gauvreau, G. E. Piercey, J. E. Lock, and K. J. Jenkins
Device Closure Rates of Simple Atrial Septal Defects Optimized by the STARFlex Device
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
538 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Orihashi, T. Sueda, K. Okada, K. Imai, K. Ban, and M. Hamamoto
Real-time three dimensional echo-guided closure of atrial septal defect: an experimental model
Interactive CardioVascular and Thoracic Surgery,
October 1, 2005;
4(5):
391 - 395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Wu, J. F. Malouf, J. A. Dearani, D. J. Hagler, G. S. Reeder, G. W. Petty, and B. K. Khandheria
Patent Foramen Ovale in Cryptogenic Stroke: Current Understanding and Management Options
Arch Intern Med,
May 10, 2004;
164(9):
950 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Earing, A. K. Cabalka, J. B. Seward, C. J. Bruce, G. S. Reeder, and D. J. Hagler
Intracardiac Echocardiographic Guidance During Transcatheter Device Closure of Atrial Septal Defect and Patent Foramen Ovale
Mayo Clin. Proc.,
January 1, 2004;
79(1):
24 - 34.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Austin
Transcatheter closure of atrial septal defects
J. Thorac. Cardiovasc. Surg.,
March 1, 2003;
125(90030):
S85 - 86.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C J McMahon, H G El Said, and C E Mullins
Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale
Heart,
August 1, 2002;
88(2):
e3 - 3.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. U. Braun, D. Fassbender, S. P. Schoen, M. Haass, R. Schraeder, W. Scholtz, and R. H. Strasser
Transcatheter closure of patent foramen ovale in patients with cerebral ischemia
J. Am. Coll. Cardiol.,
June 19, 2002;
39(12):
2019 - 2025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-D. Du, Z. M. Hijazi, C. S. Kleinman, N. H. Silverman, K. Larntz, and Amplatzer Investigators
Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial
J. Am. Coll. Cardiol.,
June 5, 2002;
39(11):
1836 - 1844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Austin
Editorial: Transcatheter closure of atrial septal defects
J. Thorac. Cardiovasc. Surg.,
December 1, 2000;
120(6):
1032 - 1033.
[Full Text]
[PDF]
|
 |
|
|